Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Supportive and palliative care

3599 - Cancer cachexia (CAX), anorexia and muscle wasting (sarcopenia) assessment in non-small cell lung cancer (NSCLC): an observational study in 531 patients


09 Sep 2017


Supportive and palliative care


Didier Debieuvre


Annals of Oncology (2017) 28 (suppl_5): v497-v501. 10.1093/annonc/mdx382


D. Debieuvre1, H. Morel2, P. Souquet3, V. Surmont4, D. Planchard5, F. Bonnetain6, I. Krakowski7, H. Gaudin8, S. Antoun9

Author affiliations

  • 1 Department Of Pneumology, Hôpital Emile Muller, 68070 - Mulhouse/FR
  • 2 Department Of Pneumology, C.H.R. Orleans - La Source, 45067 - Orleans/FR
  • 3 Department Of Pneumology, Centre Hospitalier Lyon Sud, 69495 - Pierre Bénite/FR
  • 4 Department Of Thoracic Oncology, Gent University Hospital, 9000 - Gent/BE
  • 5 Department Of Medical Oncology, GUSTAVE ROUSSY, 94805 - Villejuif/FR
  • 6 Methodological And Quality Of Life Unit In Oncology (inserm Umr 1098), CHRU Besançon Jean Minjoz, 25000 - Besançon/FR
  • 7 Département Interdisciplinaire De Soins De Support Pour Le Patient En Oncologie. (disspo-care), Institut Bergonié, 33076 - Bordeaux/FR
  • 8 Medical Affairs, Chugai Pharma France, 92042 - Paris/FR
  • 9 Unité De Médecine Aigue En Oncologie, Institut Gustave Roussy, 94805 - Villejuif/FR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 3599


Since publications highlighting the role of sarcopenia, weight loss (WL) is no longer the corner stone of malnutrition assessment. An international consensus proposed in 2011 a definition and a staging of CAX, mainly based on WL, sarcopenia, inflammation and anorexia (Fearon). We initiated this study to fill the gap of epidemiological data on CAX in NSCLC in France and Belgium.


This cross-sectional, prospective, multicentric study was conducted in Patients (pts) with NSCLC regardless of the tumor stage and the treatment line. Skeletal muscle mass (SMM) was assessed by analyzing L3 CT-scan image. Pts completed Anorexia/CAX subscale of FAACT and EORTC QLQ-C30 health related quality of life (QoL) questionnaires. Primary endpoint was the frequency of CAX according to Fearon criteria. Secondary endpoints were the frequency and the characteristics of the other stages of CAX focusing on early and discrete malnutrition changes (pre-CAX).


539 NSCLC pts were recruited within 3 months in 2016 by 56 sites, analysis population was of 531 pts and 312 had SMM assessment. Median age was 66 years, 66.5% were males, 79.9% were PS 


This is the first study showing an association between molecular abnormality in NSCLC and cachexia. It has also shown that it may be useful to detect sarcopenia in pts with limited WL (

Clinical trial identification

NCT02968979, First received: November 17, 2016

Legal entity responsible for the study

Chugai Pharma France


Chugai Pharma France


D. Debieuvre, P-J. Souquet, S. Antoun: Corporate-sponsored research: Chugai-Pharma France. H. Morel: Corporate-sponsored research: Chugai Pharma France, Roche, Astra, Lilly, MSD, Pfizer, BMS, amgen. V. Surmont: Corporate-sponsored research: Chugai-Pharma France. D. Planchard: Corporate-sponsored consultancy: AstraZeneca, Boehringer Ingelheim, BMS, Lilly, MSD, Pfizer, Roche, Novartis, Chugai Pharma France. F. Bonnetain: corporate-sponsored research: Chugai Pharma France, Amgen, Roche, Merck Serono, Nestlé, Ipsen, Jansen. I. Krakowski: Membership on an advisory board and/or symposium: Chugai Pharma France, Kyowa kirin, Pfizer, Astellas, Janssen, Takeda, P Fabre. H. Gaudin: Employee of Chugai Pharma France.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.